These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5549064)

  • 1. The plasma levels of dopa and catecholamines after oral administration of L-dopa.
    Imai K; Sugiura M; Tamura Z; Hirayama K; Narabayashi H
    Chem Pharm Bull (Tokyo); 1971 Feb; 19(2):439-40. PubMed ID: 5549064
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the metabolism and excretion of L-3,4-dihydroxyphenylalanine (L-DOPA) in human beings by gas chromatography.
    Imai K; Sugiura M; Kubo H; Tamura Z; Oya K
    Chem Pharm Bull (Tokyo); 1972 Apr; 20(4):759-64. PubMed ID: 5045616
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma catecholamines in the chronically cannulated sheep fetus: predominance of L-dihydroxyphenylalanine.
    Ben-Jonathan N; Arbogast LA; Rhoades TA; Schillo KK; Pau KY; Jackson GL
    Endocrinology; 1983 Jul; 113(1):216-21. PubMed ID: 6407822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of handling or immobilization on plasma levels of 3,4-dihydroxyphenylalanine, catecholamines, and metabolites in rats.
    Kvetnanský R; Goldstein DS; Weise VK; Holmes C; Szemeredi K; Bagdy G; Kopin IJ
    J Neurochem; 1992 Jun; 58(6):2296-302. PubMed ID: 1573408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioenzymatic assay of sulfate conjugates of catecholamines and DOPA in plasma.
    Johnson GA; Baker CA; Smith RT
    Life Sci; 1980 May; 26(19):1591-8. PubMed ID: 6770210
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of amantadine on L-2-14C-dopa metabolism in parkinsonism.
    Peaston MJ; Bianchine JR; Messiha FS
    Life Sci; 1973 Aug; 13(3):237-46. PubMed ID: 4750920
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of in vitro hemolysis on assay of plasma catecholamines and DOPA.
    Smith RT
    Clin Chem; 1980 Aug; 26(9):1354-6. PubMed ID: 6772343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of urinary dopamine from plasma dopa.
    Zimlichman R; Levinson PD; Kelly G; Stull R; Keiser HR; Goldstein DS
    Clin Sci (Lond); 1988 Nov; 75(5):515-20. PubMed ID: 3151165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma dopa responses during stress: dependence on sympathoneural activity and tyrosine hydroxylation.
    Kvetnansky R; Armando I; Weise VK; Holmes C; Fukuhara K; Deka-Starosta A; Kopin IJ; Goldstein DS
    J Pharmacol Exp Ther; 1992 Jun; 261(3):899-909. PubMed ID: 1602395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal source of plasma dihydroxyphenylalanine.
    Goldstein DS; Udelsman R; Eisenhofer G; Stull R; Keiser HR; Kopin IJ
    J Clin Endocrinol Metab; 1987 Apr; 64(4):856-61. PubMed ID: 3102548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma 3,4-dihydroxyphenylalanine (dopa) and catecholamines in neuroblastoma or pheochromocytoma.
    Goldstein DS; Stull R; Eisenhofer G; Sisson JC; Weder A; Averbuch SD; Keiser HR
    Ann Intern Med; 1986 Dec; 105(6):887-8. PubMed ID: 3096183
    [No Abstract]   [Full Text] [Related]  

  • 12. Free and conjugated plasma catecholamines, DOPA and 3-O-methyldopa in humans and in various animal species.
    Dousa MK; Tyce GM
    Proc Soc Exp Biol Med; 1988 Sep; 188(4):427-34. PubMed ID: 3138688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in L-dopa absorption. Report of a parkinsonian patient with high plasma dopa concentration after therapeutical L-dopa dose.
    Granerus AK; Jagenburg R; Rödjer S; Svanborg A
    Acta Med Scand; 1974 Dec; 196(6):459-63. PubMed ID: 4456974
    [No Abstract]   [Full Text] [Related]  

  • 14. Sources and significance of plasma levels of catechols and their metabolites in humans.
    Goldstein DS; Eisenhofer G; Kopin IJ
    J Pharmacol Exp Ther; 2003 Jun; 305(3):800-11. PubMed ID: 12649306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct method for the isolation of catecholamines in plasma.
    Minard FN; Cain JC; Grant DS
    J Pharm Pharmacol; 1975 Apr; 27(4):288-9. PubMed ID: 239126
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine generated from L-dopa: discrepancy between plasma levels and cardiac effects.
    Tjandramaga TB; Goldberg LI; Anton AH
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):424-8. PubMed ID: 4689374
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous measurement of DOPA, DOPAC, and catecholamines in plasma by liquid chromatography with electrochemical detection.
    Goldstein DS; Stull R; Zimlichman R; Levinson PD; Smith H; Keiser HR
    Clin Chem; 1984 May; 30(5):815-6. PubMed ID: 6424968
    [No Abstract]   [Full Text] [Related]  

  • 18. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
    Shigetomi S; Kuchel O
    Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption, metabolism and distribution of (14C)-O-methyldopa and (14C)-L-dopa after oral administration to rats.
    Rivera-Calimlim L
    Br J Pharmacol; 1974 Feb; 50(2):259-63. PubMed ID: 4425764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple gas chromatographic analysis of plasma dopa and dopamine.
    Mizuno Y
    Clin Chim Acta; 1977 Jan; 74(1):11-9. PubMed ID: 832410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.